Research into neurodegenerative diseases such as Parkinson’s and Alzheimer’s has traditionally focused on the accumulation of abnormal proteins in the brain and their impact on neural networks. A new study by researchers from Binghamton University and Drexel University takes a different route, highlighting the often-overlooked role of the brain’s vascular system in disease progression.
The study uses advanced organ-on-a-chip technology to investigate how Parkinson’s-related proteins affect the blood-brain barrier. This barrier, formed by endothelial cells lining the brain’s blood vessels, plays a crucial role in protecting neural tissue from harmful substances while ensuring a steady supply of oxygen and nutrients.
Assistant Professor Jungwook “Jay” Paek and his team, including Ph.D. researcher Anika Alim, applied an engineering-driven approach to simulate these processes in a controlled laboratory setting. Their findings suggest that Parkinson’s disease does not only disrupt neural communication but also significantly weakens vascular integrity. The results were published in Communications Engineering.
Organ-on-a-chip mimics human biology
The researchers used organ-on-a-chip platforms, miniaturized 3D microfluidic systems roughly the size of a USB stick, to recreate the physiological environment of the human brain. These chips allow scientists to culture living human cells and observe how tissues respond to disease-related stressors in real time.
To model Parkinson’s pathology, the team introduced aggregates of alpha-synuclein proteins, similar to the Lewy bodies found in patients. The results were striking: the presence of these protein clusters led to endothelial dysfunction, disruption of the blood-brain barrier, regression of blood vessels, and impaired blood flow.
This approach provides a dynamic and highly observable alternative to traditional models, offering insights that are difficult to obtain from static imaging or animal studies. It also demonstrates how engineering and life sciences are increasingly converging to tackle complex medical challenges.
Implications for diagnosis and treatment
The study underscores the importance of looking beyond neurons alone when studying neurodegenerative diseases. According to the researchers, vascular damage may play a significant role in accelerating disease progression by exposing neurons to harmful circulating substances and reducing the delivery of essential nutrients.
By integrating these findings with artificial intelligence models, future research could improve predictions of disease progression and support the development of targeted therapies. Understanding the interplay between protein aggregation and vascular dysfunction may ultimately open new avenues for intervention.
The researchers emphasize that Parkinson’s is a multifaceted condition requiring equally multifaceted research strategies. Bridging the gap between neurobiology and vascular science could lead to more comprehensive treatment approaches, improving outcomes and quality of life for patients.
As organ-on-a-chip technology continues to evolve, it is poised to become a key tool in translational research, bringing laboratory discoveries closer to clinical application.